IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. 

Biotechnology

IO Biotech

IO Biotech's headquarters in København, Denmark

Mai-Britt Zocca

Muhammad Al-Hajj

Amy Sullivan

Kathe Errity

Faical Miyara Ph.d

Dr. Qasim Iftikhar Ahmad

Qasim Ahmad

Devin Smith

Inge Marie Svane

Vanessa Malier

Kapil Dhingra

Peter Hirth

David V. Smith

Kathleen Sereda Glaub

Christian Elling

Mads Hald Andersen

Alexander Eggermont

Jack B. Nielsen

Heidi Hunter

The Research and Development team at IO Biotech is responsible for advancing the company's innovative immune therapies for cancer treatment. This team conducts cutting-edge research to develop and optimize their unique platform technology, which activates T cells specific to immune inhibitory molecules, ultimately aiming to bring first-in-class immune modulating therapies from the lab to clinical trials.

Research and Development

The Regulatory and Clinical Operations team at IO Biotech is responsible for overseeing the clinical trial processes, ensuring regulatory compliance, and managing patient safety. They develop strategies to navigate complex regulatory environments, maintain adherence to clinical guidelines, and lead initiatives for regulatory submissions and approvals to advance IO Biotech's innovative immuno-oncology therapies.

Regulatory and Clinical Operations

The Finance and Accounting team at IO Biotech manages the financial health of the company, ensuring accurate financial reporting, budgeting, and compliance with regulatory standards. They provide strategic financial guidance to support the development and commercialization of IO Biotech’s innovative cancer immunotherapies.

Finance and Accounting

The Leadership Team at IO Biotech is responsible for guiding the company's strategic direction and overseeing the development of innovative immune therapies for cancer treatment. This team integrates expertise in translational research and corporate leadership to drive the advancement of first-in-class therapies, ensuring alignment with the company's mission and maximizing the impact of their unique platform technology on patient outcomes.

Leadership Team

The Clinical Operations Team at IO Biotech is responsible for the planning, execution, and management of clinical trials to evaluate the efficacy and safety of the company's novel immune therapies for cancer. This team ensures regulatory compliance, oversees data collection and management, and collaborates with various stakeholders to facilitate successful clinical development programs.

��

IO Biotech

Org chart

Board & advisors

Teams

Research and Development

Regulatory and Clinical Operations

Finance and Accounting

Leadership Team

Clinical Operations Team

Offices

��������

IO Biotech

Org chart

Board & advisors

Teams

Research and Development

Regulatory and Clinical Operations

Finance and Accounting

Leadership Team

Clinical Operations Team

Offices

Related companies

��